XBiotech XBIT
$ 6.57
1.23%
Quarterly report 2024-Q3
added 11-13-2024
XBiotech Financial Statements 2011-2024 | XBIT
Annual Financial Statements XBiotech
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
180 M | 103 M | 334 M | 544 M | 881 M | 231 M | 171 M | 376 M | 254 M | - | - | - | - |
Shares |
30.4 M | 30.4 M | 30 M | 29 M | 38.9 M | 35.8 M | 34.9 M | 32.4 M | 30.8 M | - | - | - | - |
Historical Prices |
5.91 | 3.38 | 11.1 | 13.5 | 16.1 | 4.38 | 3.39 | 8.72 | 9.37 | - | - | - | - |
Net Income |
-4.64 M | -3.2 M | -6.47 M | -11.2 M | 669 M | -21.1 M | -33.2 M | -52.8 M | -37.5 M | -21.7 M | -9.93 M | -15.2 M | - |
Revenue |
- | 4.01 M | 18.4 M | 44 M | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
- | 651 K | 5.82 M | 34.5 M | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | 3.36 M | 12.6 M | 9.45 M | - | - | - | - | - | - | - | - | - |
Operating Income |
-8.59 M | -8.16 M | -7.19 M | -18.3 M | -31.2 M | -21 M | -34.1 M | -52.8 M | -37.5 M | -21.8 M | -9.92 M | - | - |
Interest Expense |
883 K | -121 K | -132 K | -503 K | 10 K | 4 K | - | - | - | - | - | - | - |
EBITDA |
-6.84 M | -5.55 M | -4.54 M | -16 M | -28.9 M | -18.6 M | -32.6 M | -52.1 M | -36.8 M | -21.2 M | -9.14 M | -14.2 M | - |
Operating Expenses |
37.5 M | 37.8 M | 37.7 M | 27.7 M | 31.2 M | 21 M | 34.1 M | 52.8 M | 37.5 M | - | - | - | - |
General and Administrative Expenses |
4.66 M | 6.3 M | 9.39 M | 18.2 M | 7.14 M | 5.27 M | 7.64 M | 10.3 M | 6.2 M | 7.45 M | 1.99 M | 1.83 M | - |
All numbers in USD currency
Quarterly Income Statement XBiotech
2024-Q3 | 2024-Q2 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shares |
30.5 M | 30.5 M | 30.4 M | 30.4 M | 30.4 M | 30.4 M | 30.4 M | 30.4 M | 30.4 M | 30.4 M | 30.4 M | 30.3 M | 30 M | 29.4 M | 29.3 M | 29 M | 28.9 M | 36.2 M | 41.5 M | 41 M | 37.5 M | 36 M | 35.9 M | 35.8 M | 35.8 M | 35.4 M | 35.4 M | 35.4 M | 35.3 M | 33.3 M | 32.6 M | 32.4 M | 32.4 M | 32.3 M | 32.3 M | 32.1 M | 31.3 M | 27.6 M | 27.5 M | 24.1 M | 23.7 M | 23.6 M | - | - | - | - | - | - | - | - | - | - | - | - |
Net Income |
-5.02 M | -13 M | - | -7.36 M | -8.74 M | -3.82 M | - | -12.7 M | -11.6 M | -5.4 M | -6.47 M | -3.26 M | -5.12 M | -2.57 M | -1.84 M | -2.53 M | -6.84 M | -14 K | 686 M | -6.15 M | -5.85 M | -5.86 M | -6.11 M | -5.05 M | -5.91 M | -4.07 M | -7.25 M | -6.2 M | -9.13 M | -10.6 M | -16.4 M | -12.5 M | -13.6 M | -10.3 M | - | -10.7 M | -6.74 M | -8.11 M | - | -6.96 M | -3.91 M | -4.5 M | - | - | - | - | - | - | - | - | - | - | - | - |
Revenue |
- | - | - | - | - | - | - | 1.68 M | 1.53 M | 500 K | - | 4.52 M | 4.52 M | 4.85 M | - | 10.5 M | 15.5 M | 12.7 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
- | - | - | - | - | - | - | 215 K | 207 K | 213 K | - | 1.11 M | 1.36 M | 2.3 M | - | 9.43 M | 13.2 M | 9.67 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | 1.46 M | 1.32 M | 287 K | - | 3.41 M | 3.16 M | 2.55 M | - | 1.12 M | 2.3 M | 3.01 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
-7.9 M | -15 M | - | -8.52 M | -13.3 M | -7.14 M | - | -6.39 M | -12.1 M | -7.84 M | -7.19 M | -3.73 M | -10.6 M | -3.55 M | -4.92 M | -4.67 M | -6.51 M | -2.17 M | -13.3 M | -6.11 M | -6.01 M | -5.8 M | -6.11 M | -5.12 M | -5.62 M | -4.15 M | -7.51 M | -6.59 M | -9.69 M | -10.3 M | -16.4 M | -12.5 M | -13.6 M | -10.2 M | - | 10.8 M | 6.42 M | -8.2 M | - | -6.98 M | -3.9 M | -4.5 M | - | - | - | - | - | - | - | - | - | - | - | - |
Interest Expense |
25 K | -200 K | - | - | 750 K | 130 K | - | - | -119 K | - | - | -121 K | -2 K | -10 K | - | - | -503 K | - | - | - | 1 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA |
- | - | - | - | - | -6.7 M | - | -4.22 M | -10.7 M | -7.14 M | -7.19 M | -1.78 M | -9.35 M | -2.93 M | -4.92 M | -3.02 M | -5.41 M | -1.61 M | -13.3 M | -4.32 M | -4.81 M | -5.2 M | -6.11 M | -3.3 M | -4.42 M | -3.56 M | -7.51 M | -5.7 M | -9.1 M | -9.98 M | -16.4 M | -11.9 M | -13.3 M | -10.1 M | - | 11.3 M | 6.76 M | -8.04 M | - | -6.55 M | -3.62 M | -4.36 M | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Expenses |
7.9 M | 15 M | - | 8.52 M | 13.3 M | 7.14 M | - | 7.85 M | 13.4 M | 8.13 M | - | 7.14 M | 13.8 M | 6.1 M | - | 5.79 M | 8.81 M | 5.18 M | - | 6.11 M | 6.01 M | 5.8 M | - | 5.12 M | 5.62 M | 4.15 M | - | 6.59 M | 9.69 M | 10.3 M | - | 12.5 M | 13.6 M | 10.2 M | - | 10.8 M | 6.42 M | 8.2 M | - | 6.98 M | 3.9 M | 4.5 M | - | - | - | - | - | - | - | - | - | - | - | - |
General and Administrative Expenses |
777 K | 1.98 M | - | 973 K | 1.99 M | 915 K | - | 840 K | 3.02 M | 1.31 M | - | 1.54 M | 4.52 M | 1.46 M | - | 3.45 M | 6.25 M | 4.02 M | - | 1.58 M | 1.31 M | 1.28 M | - | 1.18 M | 1.67 M | 1.16 M | - | 1.66 M | 2.29 M | 2.08 M | - | 2.68 M | 2.4 M | 2.44 M | - | 1.08 M | 2.04 M | 1.42 M | - | 2.64 M | 659 K | 2.15 M | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency